VENCLEXTA is a BCL-2 inhibitor indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion, as detected by an FDA approved test, who have received at least one prior therapy. This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

Where can I buy Venclexta?

Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its presence PAN India with over 20 years of domain experience.

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Venclexta (venetoclax) on prescription and Import License in Patient's Name only.

For Venclexta (venetoclax) tablets price in India.
Please contact +91 9811747774 or neeraj@indianpharmanetwork.co.in
Venclexta (venetoclax)

Get In Touch

Facilitator under Patient Assistance Programs In India

For Indian Patients, doctors and hospitals Venclexta (venetoclax) can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Dosage Forms and Strengths

Tablets: 10 mg, 50 mg, 100 mg

ReadMore

Immuno Oncology News

Venclexta-Rituxan Combo Delays Disease Progression in Lymphocytic Leukemia, Trial Results Show.
Dated: MARCH 26, 2018

ReadMore